Cytosorbents Corporation - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS

Ticker Exchange SIC # Website Latest Ticker
CTSO Nasdaq 3841 www.cytosorbents.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Cytosorbents Corporation

CTSO: CytoSorbents Price Target Increased to $5.00 Based on Higher Than Expected Gross Margins - Jan 13th, 2026 6:08 am
CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results and Business Update - Jan 12th, 2026 5:00 am
CytoSorbents to Participate in a Virtual Fireside Chat with D. Boral Capital on Monday, December 15, 2025 - Dec 10th, 2025 5:00 am
Updated: CytoSorbents to Present at the Jefferies Global Healthcare Conference in London - Nov 17th, 2025 3:42 pm
CTSO: CytoSorbents High Margin Revenue Growth Supports Price Target of $4.00 - Nov 17th, 2025 2:21 am
CytoSorbents Corp (CTSO) Q3 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ... - Nov 13th, 2025 10:03 pm
Cytosorbents (CTSO) Q3 2025 Earnings Transcript - Nov 13th, 2025 3:14 pm
CytoSorbents: Q3 Earnings Snapshot - Nov 13th, 2025 2:58 pm
CytoSorbents Reports Third Quarter 2025 Financial Results and Provides Business Update - Nov 13th, 2025 2:05 pm
CytoSorbents to Participate at the Jefferies Global Healthcare Conference in London - Nov 11th, 2025 5:00 am
CytoSorbents to Report Third Quarter 2025 Financial Results and Recent Business Highlights - Oct 30th, 2025 5:00 am
In Memoriam: Dr. Robert Hawes Bartlett (1939-2025) - Father of Extracorporeal Membrane Oxygenation (ECMO) and Former CytoSorbents Chief Medical Officer - Oct 28th, 2025 5:00 am
CytoSorbents to Showcase Pioneering New Cardiac Surgery Data in Key Applications at the EACTS 2025 Annual Meeting in Copenhagen - Sep 29th, 2025 5:00 am
The past five years for Cytosorbents (NASDAQ:CTSO) investors has not been profitable - Sep 20th, 2025 8:21 am
CytoSorbents Provides DrugSorb-ATR Regulatory Update - Sep 16th, 2025 5:00 am
CytoSorbents To Host Global Webinar on "Turning the Tide in Sepsis and Septic Shock: Real World Insights with CytoSorb" in Recognition of World Sepsis Day - Sep 8th, 2025 5:00 am
CytoSorbents to Present at the H.C. Wainwright 27th Annual Global Investment Conference - Sep 5th, 2025 5:00 am
CTSO: CytoSorbents Announces the De Novo denial on DrugSorb-ATR was upheld by the FDA. However, a Path to Approval Was Also Provided by the Agency. - Aug 20th, 2025 9:00 am
CytoSorbents Updates U.S. FDA Regulatory Status of DrugSorb-ATR - Aug 20th, 2025 5:00 am
Cytosorbents Second Quarter 2025 Earnings: Beats Expectations - Aug 10th, 2025 6:36 am